To unlock the power of data for advanced medical insights.
Company & History
apoplex medical technologies GmbH
apoplex medical technologies has been at the forefront of stroke prevention for over 20 years, specializing in the development of applications to support atrial fibrillation detection. The core element of our stroke risk analysis solutions SRA®, SRA®+, and the upcoming SRA® Pro is the fully automated detection of indications of atrial fibrillation as well as the identification of patients with an increased probability of paroxysmal atrial fibrillation in flicker-free episodes.
More than 20 peer-reviewed studies have shown that our SRA® system not only improves patient care but also streamlines clinical workflows and optimizes operational efficiency. Trusted by 40% of stroke units in Germany, SRA® has become a cornerstone in reshaping patient pathways and supporting healthcare professionals in preventing strokes.
We work closely with healthcare professionals to develop disruptive technologies rooted in clinical evidence. By advancing stroke prevention, we aim to save lives and significantly reduce the number of strokes caused by undetected atrial fibrillation.
Our History
Key Facts
Our Medical Advisory Board
Dr. Ignacio H. Medrano
Neurologist. Founder at Savana & at Mendelian Savana Singularity University
Dr. Ignacio H. Medrano
Dr. Ignacio H. Medrano is a Consultant Neurologist with additional training in Healthcare Management and extensive experience in clinical research strategy. A graduate of Singularity University, he combines medical expertise with technological innovation.
He is the founder of Mendelian, a UK-based company using artificial intelligence to support the diagnosis of rare diseases, and Savana, which applies AI to analyze electronic medical records for clinical research.
In 2021, Forbes named him one of the 100 most creative Spaniards in business, and in 2023 he was included in the list of 23 changemakers. Dr. Medrano is also an internationally recognized speaker, presenting at institutions including the European Commission and the Royal Academy of Science in the UK.
Dr. Thomas Johannes Neuberger
Senior Physician Internal Medicine & Cardiology Medical Manager at Apoplex
Dr. Thomas Johannes Neuberger
Dr. Thomas Johannes Neuberger is a Specialist in Internal Medicine and Cardiology with extensive clinical experience in cardiovascular care. Since 2011 he has served as Senior Physician in Internal Medicine and Cardiology at Pirmasens Hospital, and since 2014 he has also worked as Medical Manager at Apoplex Medical Technologies GmbH, focusing on innovative cardiovascular diagnostics.
He studied Medicine at Goethe University Frankfurt and earned his doctorate with research on Heart Rate Turbulence as an autonomic marker for arrhythmia risk stratification, contributing to advances in cardiac risk assessment.
Dr. Lucio D’Anna
Consultant Neurologist at Imperial College Healthcare NHS Trust
Dr. Lucio D’Anna
Dr. Lucio D’Anna works within Stroke & Neurosciences at Imperial College Healthcare NHS Trust and also holds an academic appointment as an Honorary Senior Lecturer in the Division of Brain Sciences at Imperial College London. He also serves as the North West London Stroke Operational Lead, contributing to the strategic organisation and delivery of stroke services across the region.
His clinical and research work spans neurology and stroke medicine, with a particular focus on atrial fibrillation-related stroke, anticoagulation strategies, and secondary prevention. His research interests include early-stage clinical studies, advanced neuroimaging, and the development and validation of innovative diagnostic approaches and targeted treatments for patients with stroke.
